Suppr超能文献

通过整合全基因组分析和 CRISPR/Cas9 基因组编辑技术解析组织特异性超级增强子。

Dissecting Tissue-Specific Super-Enhancers by Integrating Genome-Wide Analyses and CRISPR/Cas9 Genome Editing.

机构信息

Department of Biological Sciences, Sookmyung Women's University, Seoul, 04310, Republic of Korea.

Laboratory of Genetics and Physiology, National Institutes of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, 20892, USA.

出版信息

J Mammary Gland Biol Neoplasia. 2019 Mar;24(1):47-59. doi: 10.1007/s10911-018-9417-z. Epub 2018 Oct 6.

Abstract

Recent advances in genome-wide sequencing technologies have provided researchers with unprecedented opportunities to discover the genomic structures of gene regulatory units in living organisms. In particular, the integration of ChIP-seq, RNA-seq, and DNase-seq techniques has facilitated the mapping of a new class of regulatory elements. These elements, called super-enhancers, can regulate cell-type-specific gene sets and even fine-tune gene expression regulation in response to external stimuli, and have become a hot topic in genome biology. However, there is scant genetic evidence demonstrating their unique biological relevance and the mechanisms underlying these biological functions. In this review, we describe a robust genome-wide strategy for mapping cell-type-specific enhancers or super-enhancers in the mammary genome. In this strategy, genome-wide screening of active enhancer clusters that are co-occupied by mammary-enriched transcription factors, co-factors, and active enhancer marks is used to identify bona fide mammary tissue-specific super-enhancers. The in vivo function of these super-enhancers and their associated regulatory elements may then be investigated in various ways using the advanced CRISPR/Cas9 genome-editing technology. Based on our experience targeting various mammary genomic sites using CRISPR/Cas9 in mice, we comprehensively discuss the molecular consequences of the different targeting methods, such as the number of gRNAs and the dependence on their simultaneous or sequential injections. We also mention the considerations that are essential for obtaining accurate results and shed light on recent progress that has been made in developing modified CRISPR/Cas9 genome-editing techniques. In the future, the coupling of advanced genome-wide sequencing and genome-editing technologies could provide new insights into the complex genetic regulatory networks involved in mammary-gland development.

摘要

近年来,全基因组测序技术的进步为研究人员提供了前所未有的机会,使他们能够发现生物体内基因调控单元的基因组结构。特别是,ChIP-seq、RNA-seq 和 DNase-seq 技术的整合促进了一类新的调控元件的绘制。这些元件被称为超级增强子,可以调控细胞类型特异性的基因集,甚至可以精细调节基因表达调控以响应外部刺激,已成为基因组生物学的热门话题。然而,很少有遗传证据表明它们具有独特的生物学相关性,以及这些生物学功能的潜在机制。在这篇综述中,我们描述了一种强大的全基因组策略,用于绘制乳腺基因组中细胞类型特异性增强子或超级增强子。在这种策略中,使用乳腺富集转录因子、辅助因子和活性增强子标记共同占据的活跃增强子簇的全基因组筛选,来鉴定真正的乳腺组织特异性超级增强子。然后,可以使用先进的 CRISPR/Cas9 基因组编辑技术,以各种方式研究这些超级增强子及其相关调控元件的体内功能。基于我们在小鼠中使用 CRISPR/Cas9 靶向各种乳腺基因组位点的经验,我们全面讨论了不同靶向方法的分子后果,例如 gRNA 的数量以及对其同时或顺序注射的依赖性。我们还提到了获得准确结果所必需的考虑因素,并阐明了在开发改良的 CRISPR/Cas9 基因组编辑技术方面取得的最新进展。在未来,先进的全基因组测序和基因组编辑技术的结合可能会为乳腺发育中涉及的复杂遗传调控网络提供新的见解。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验